Rebel Medicine develops proprietary injectable drug delivery technologies that extend the duration of proven drug molecules from days to months. Our lead program is an injectable long-acting local anesthetic engineered to control postoperative pain for 4-5 days and mitigate the use of opioids after surgery. Pipeline programs include once-monthly delivery of incretin peptides for metabolic diseases. Our versatile delivery technologies are broadly applicable across multiple drug classes, offering partnership opportunities to unlock long-acting potential in both new and existing therapeutics.